Psychiatry

814 soru

Soru 61Soru →

A 24-year-old woman is brought to the emergency department by her friends due to severe agitation, confusion, and high fever. The friends report that she was at an electronic dance music festival earlier in the evening where she ingested a "party pill." Her medical history is notable for treatment-resistant depression, for which she currently takes tranylcypromine. Her temperature is 39.8°C (103.6°F), blood pressure is 165/95 mmHg, and pulse is 128/min. Physical examination shows pronounced diaphoresis, dilated pupils, generalized hyperreflexia, and bilateral ankle clonus. Bowel sounds are hyperactive. Which of the following substances did this patient most likely ingest?

Cevabı ve açıklamayı göster

Cevap: 3,4-methylenedioxymethamphetamine

Cevap

The correct answer is 3,4-methylenedioxymethamphetamine (MDMA), which precipitated serotonin syndrome due to its interaction with the patient's MAOI.
The correct answer is 3,4-methylenedioxymethamphetamine (MDMA). This patient's presentation of severe autonomic instability (hyperthermia, hypertension, tachycardia), altered mental status (agitation, confusion), and distinct neuromuscular hyperactivity (hyperreflexia, bilateral ankle clonus) is classic for serotonin syndrome. MDMA is a synthetic amphetamine derivative commonly used as a club drug that triggers a massive release of serotonin, dopamine, and norepinephrine into the synaptic cleft. Tranylcypromine is a monoamine oxidase inhibitor (MAOI) that blocks the degradation of monoamines, including serotonin. The combination of a massive serotonin releaser (MDMA) and an MAOI (tranylcypromine) creates a dangerous, potentially fatal pharmacokinetic interaction resulting in excessive synaptic serotonin and severe serotonin syndrome. The presence of clonus and hyperreflexia are the key differentiating features that separate serotonin syndrome from other toxidromes.

Adım Adım Çözüm

1
Identify the primary toxidrome from the physical examination and vital signs.
The patient has hyperthermia, hypertension, tachycardia, altered mental status, generalized hyperreflexia, ankle clonus, and hyperactive bowel sounds.
Recognizing the triad of autonomic instability, altered mental status, and neuromuscular irritability (specifically clonus and hyperreflexia) is essential to diagnose serotonin syndrome.
2
Analyze the patient's medication history for potential pharmacological interactions.
The patient is taking tranylcypromine, a monoamine oxidase inhibitor (MAOI).
MAOIs inhibit the breakdown of monoamines, greatly increasing the risk of serotonin syndrome when combined with serotonergic agents.
3
Determine which illicit substance would interact with the MAOI to produce the observed toxidrome.
3,4-methylenedioxymethamphetamine (MDMA) acts as a massive serotonin releaser. When combined with an MAOI, it prevents serotonin breakdown, leading to life-threatening serotonin syndrome.
Connecting the club drug exposure to its pharmacological mechanism identifies MDMA as the culprit.

Anahtar Kavram

Combining a monoamine oxidase inhibitor (MAOI) with a strong serotonergic agent like MDMA can precipitate life-threatening serotonin syndrome, characterized by autonomic instability, altered mental status, and neuromuscular irritability (e.g., hyperreflexia, clonus).
Soru 62Soru →

Match each patient's clinical presentation of an antipsychotic-induced adverse effect with the most appropriate specific pharmacological management strategy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 25-year-old man develops severe, sustained torticollis and upward gaze deviation (oculogyric crisis) 12 hours after a dose of intramuscular haloperidol.
A 32-year-old woman recently started on aripiprazole reports a distressing, constant urge to move and is observed continuously shifting her weight and pacing.
A 48-year-old man taking perphenazine for several months presents with new-onset generalized psychomotor slowing, a shuffling gait, and resting tremor.
A 55-year-old woman on long-term risperidone therapy develops involuntary, repetitive lip-smacking and chewing movements with choreoathetosis of her hands.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Acute dystonia matches with IM/IV anticholinergics or antihistamines. Akathisia matches with dose reduction and a beta-blocker. Drug-induced parkinsonism matches with oral benztropine or amantadine. Tardive dyskinesia matches with tapering the drug, switching to clozapine, or using a VMAT2 inhibitor.
Each extrapyramidal symptom has a specific timeline and treatment protocol. Acute dystonia (muscle spasm within hours) requires immediate anticholinergics. Akathisia (restlessness within days) requires beta-blockers. Parkinsonism (bradykinesia within weeks) requires amantadine or oral anticholinergics. Tardive dyskinesia (choreoathetosis over years) requires VMAT2 inhibitors or switching to clozapine.

Adım Adım Çözüm

1
Identify the specific extrapyramidal symptom (EPS) based on the clinical presentation and timeline.
Patient 1 has acute dystonia (hours), Patient 2 has akathisia (days to weeks), Patient 3 has parkinsonism (weeks to months), and Patient 4 has tardive dyskinesia (months to years).
Accurate identification of the specific movement disorder and its onset timeline is required to select the correct treatment algorithm.
2
Select the evidence-based pharmacological intervention for each specific condition.
Dystonia -> Benztropine/Diphenhydramine (IM/IV). Akathisia -> Beta-blocker (Propranolol). Parkinsonism -> Benztropine/Amantadine (Oral). Tardive Dyskinesia -> VMAT2 inhibitor/Switch to Clozapine.
Different extrapyramidal symptoms have distinct underlying mechanisms (e.g., acute dopamine blockade vs. dopamine receptor upregulation) and therefore require completely different pharmacological strategies.

Anahtar Kavram

Management of Antipsychotic-Induced Extrapyramidal Symptoms
Tahmini Süre:1m 30s
Soru 63Soru →

Antipsychotic medications modulate dopamine activity across various neural circuits, leading to both therapeutic effects and distinct adverse reactions. Match each clinical presentation described below to the specific dopaminergic pathway whose dopamine D2 receptor blockade is most directly responsible for the observed outcome.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Significant reduction in persecutory delusions and commanding auditory hallucinations following initiation of haloperidol.
Development of severe bradykinesia, masked facies, and cogwheel rigidity two weeks after increasing the dose of risperidone.
Onset of secondary amenorrhea and milky breast discharge in a female patient treated with a high-potency first-generation antipsychotic.
Worsening of social withdrawal, avolition, and flattened affect following the initiation of high-dose fluphenazine.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations map to the following pathways: Positive symptom relief is due to mesolimbic blockade. Parkinsonian symptoms are due to nigrostriatal blockade. Galactorrhea and amenorrhea are due to tuberoinfundibular blockade. Worsening negative symptoms are due to mesocortical blockade.
Each clinical outcome specifically maps to the physiological function of its underlying dopaminergic circuit when subjected to dopamine D2 receptor antagonism.

Adım Adım Çözüm

1
Identify the pathway targeted for the therapeutic relief of psychotic symptoms.
The mesolimbic pathway.
Hyperactivity in the mesolimbic circuit drives positive symptoms like hallucinations and delusions; D2 blockade here provides the primary therapeutic efficacy of antipsychotics.
2
Recognize the pathway associated with the regulation of voluntary movement.
The nigrostriatal pathway.
This pathway connects the substantia nigra to the striatum. Disruption of dopamine transmission here causes extrapyramidal symptoms like drug-induced parkinsonism.
3
Determine the pathway responsible for endocrine regulation related to prolactin.
The tuberoinfundibular pathway.
Dopamine acts as a prolactin-inhibiting factor in this pathway. Blocking D2 receptors removes this inhibition, leading to hyperprolactinemia and subsequent galactorrhea/amenorrhea.
4
Identify the circuit linked to affect, motivation, and cognitive functioning.
The mesocortical pathway.
Hypofrontality and reduced dopaminergic tone in the mesocortical pathway correlate with negative symptoms. Antipsychotics can worsen these symptoms by further blocking dopamine in this area.

Anahtar Kavram

The clinical effects of antipsychotic medications correlate with their activity across four distinct dopaminergic pathways: mesolimbic (therapeutic efficacy for positive symptoms), mesocortical (exacerbation of negative symptoms), nigrostriatal (extrapyramidal symptoms), and tuberoinfundibular (hyperprolactinemia).
Soru 64Soru →

A collegiate gymnast presents to the student health center for evaluation of a persistently depressed mood, profound fatigue, and anhedonia over the past three months. During the interview, she expresses deep dissatisfaction with her body shape and an intense fear of gaining weight. Vital signs show a heart rate of 54 /min54 \text{ /min} and a blood pressure of 92/58 mm Hg92/58 \text{ mm Hg}. Physical examination reveals a body mass index of 17.4 kg/m217.4 \text{ kg/m}^2, fine downy hair on her arms, and bilateral parotid gland enlargement. Laboratory results are notable for a serum potassium of 3.2 mEq/L3.2 \text{ mEq/L}. She asks the physician to prescribe an antidepressant she read about online, describing it as 'the one that does not cause weight gain or sexual problems.' If the physician complies and prescribes this specific medication, the patient would be at significantly increased risk for which of the following complications?

Cevabı ve açıklamayı göster

Cevap: Generalized seizures

Cevap

Generalized seizures
The correct answer is generalized seizures. The patient's clinical presentation—including a low body mass index, bradycardia, lanugo (fine downy hair), parotid gland enlargement, and hypokalemia—is highly indicative of an eating disorder with purging behavior. She is requesting an antidepressant that is weight-neutral and lacks sexual side effects, which accurately describes bupropion. Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) that is known to lower the seizure threshold in a dose-dependent manner. It is absolutely contraindicated in patients with anorexia nervosa or bulimia nervosa. These conditions frequently cause severe electrolyte abnormalities (such as this patient's hypokalemia) that independently lower the seizure threshold, placing the patient at an extreme risk for developing generalized tonic-clonic seizures if bupropion is administered.

Adım Adım Çözüm

1
Identify the patient's underlying psychiatric and medical condition based on the clinical presentation.
The patient has major depressive disorder comorbid with an eating disorder (anorexia nervosa, binge-eating/purging type), indicated by her low BMI, intense fear of weight gain, bradycardia, lanugo, parotid enlargement, and hypokalemia.
Recognizing the comorbid eating disorder and its physiologic consequences (electrolyte abnormalities) is crucial for safe psychopharmacologic selection.
2
Identify the specific medication the patient is requesting based on her description.
The medication requested is bupropion, a norepinephrine-dopamine reuptake inhibitor (NDRI).
Bupropion is uniquely known among antidepressants for being weight-neutral (or causing weight loss) and having an absence of sexual side effects.
3
Determine the primary adverse risk and contraindication of the requested medication in this specific patient population.
Bupropion causes a dose-dependent lowering of the seizure threshold and is therefore strictly contraindicated in patients with anorexia nervosa or bulimia nervosa.
Patients with eating disorders frequently suffer from electrolyte derangements (like this patient's hypokalemia) that independently lower the seizure threshold, making the administration of bupropion highly epileptogenic.

Anahtar Kavram

Bupropion is an activating antidepressant that lacks sexual side effects and does not cause weight gain, but it is strictly contraindicated in patients with eating disorders (anorexia and bulimia nervosa) due to an unacceptably high risk of generalized seizures.
Soru 65Soru →

A medical student on a psychiatry clerkship is reviewing the adverse effect profiles of commonly prescribed psychiatric medications. Match each of the following psychotropic medications to the clinical vignette that best describes its characteristic adverse effect or toxicity.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Clozapine
Lamotrigine
Lithium
Bupropion
Ziprasidone

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Clozapine matches with agranulocytosis; Lamotrigine matches with Stevens-Johnson syndrome; Lithium matches with toxicity exacerbated by thiazides; Bupropion matches with seizures in eating disorders; Ziprasidone matches with QTc prolongation.
Each psychotropic medication has a unique, high-yield adverse effect profile that must be recognized to ensure patient safety. Clozapine requires strict ANC monitoring due to agranulocytosis risk. Lamotrigine must be titrated slowly to prevent Stevens-Johnson syndrome. Lithium has a narrow therapeutic window, and toxicity is easily precipitated by volume depletion or thiazides. Bupropion lowers the seizure threshold and is contraindicated in eating disorders. Ziprasidone is strongly associated with QTc prolongation.

Adım Adım Çözüm

1
Analyze the side effect profile for Clozapine.
Identify that Clozapine can cause life-threatening agranulocytosis, presenting with fever, sore throat, and low ANC.
This is a mandatory safety parameter monitored via the REMS program.
2
Analyze the side effect profile for Lamotrigine.
Identify that Lamotrigine can cause Stevens-Johnson syndrome, a severe blistering mucosal rash, especially with fast titration.
Understanding titration protocols is essential to prevent this dermatologic emergency.
3
Analyze the side effect profile for Lithium.
Identify that Lithium causes nephrogenic diabetes insipidus and has a narrow therapeutic index; toxicity (ataxia, tremor) is worsened by thiazide diuretics.
Drug-drug interactions are critical in managing patients on mood stabilizers.
4
Analyze the side effect profile for Bupropion.
Identify that Bupropion lowers the seizure threshold, making it contraindicated in bulimia nervosa due to electrolyte imbalances.
Matching contraindications with patient history ensures safe prescribing.
5
Analyze the side effect profile for Ziprasidone.
Identify that Ziprasidone is associated with significant QTc prolongation.
ECG monitoring may be required to prevent arrhythmias like torsades de pointes.

Anahtar Kavram

Psychotropic Medication Adverse Effects
Soru 66Soru →

A 28-year-old woman presents to the clinic complaining of feeling "down" and "exhausted" for the past month. She reports struggling to get out of bed, losing interest in her hobbies, and experiencing a 3-kg (6.6-lb) weight gain. She has difficulty concentrating at work. Four years ago, she had a period lasting about a week where she felt "on top of the world," required only 3 hours of sleep a night, and started a business that quickly failed, accumulating significant debt. She is currently not taking any medications. Her vital signs are temperature 37.0°C (98.6°F), blood pressure 110/70 mm Hg, pulse 72/min, and respirations 14/min. Physical examination shows no abnormalities. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 2.1 mU/L2.1 \text{ mU/L} and a free thyroxine (T4) level of 1.2 ng/dL1.2 \text{ ng/dL}. Which of the following is the most appropriate initial pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Quetiapine

Cevap

Quetiapine
The correct answer is quetiapine. This patient presents with a major depressive episode, but her history of a distinct period of abnormally elevated mood, decreased need for sleep, and risky financial behavior lasting a week meets the criteria for a manic episode. Therefore, her diagnosis is bipolar I disorder, currently in a depressed episode. The first-line treatment for bipolar depression includes certain second-generation antipsychotics (e.g., quetiapine, lurasidone) or mood stabilizers (e.g., lithium, lamotrigine). Quetiapine effectively treats the depressive symptoms without significantly increasing the risk of a manic switch.

Adım Adım Çözüm

1
Analyze the patient's current symptoms.
The patient has a 1-month history of depressed mood, fatigue, anhedonia, weight gain, and poor concentration, which are indicative of a major depressive episode.
To establish the current clinical state.
2
Review the patient's psychiatric history.
The patient had a 1-week episode of elevated mood, decreased need for sleep, and risky behavior 4 years ago.
To determine if the patient has a history of mania or hypomania, which fundamentally alters the diagnosis and management.
3
Synthesize the findings to formulate a diagnosis.
A history of a manic episode combined with a current major depressive episode is diagnostic of Bipolar I disorder, currently in a depressed episode.
To guide the selection of appropriate pharmacotherapy.
4
Select the appropriate treatment for bipolar depression.
Quetiapine is selected as it is approved for the treatment of bipolar depression and does not carry a high risk of inducing a manic switch.
Antidepressant monotherapy must be avoided in bipolar disorder due to the significant risk of precipitating mania.

Anahtar Kavram

Patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania to rule out bipolar disorder before initiating therapy, as antidepressant monotherapy can precipitate a manic switch.
Soru 67Soru →

During a routine wellness check, a 42-year-old male executive reports feeling constantly "on edge" and exhausted. Upon further questioning, he reveals that for the past 8 months, he has been overwhelmingly worried about various issues including his company's performance, his children's academic success, and his mortgage. He states, "I just can't turn my brain off." He also notes frequent neck stiffness and difficulty falling asleep. He denies any depressed mood, sudden rushes of fear, or repetitive rituals. He drinks one cup of coffee daily and does not use illicit substances. Vital signs are within normal limits. Physical examination shows tense trapezius muscles but is otherwise unremarkable. Thyroid-stimulating hormone (TSH) level is normal. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Generalized anxiety disorder

Cevap

Generalized anxiety disorder
The correct diagnosis is Generalized anxiety disorder because the patient describes excessive, persistent, and uncontrollable worry about various aspects of life (work, family, finances) occurring more days than not for at least 6 months. Additionally, he exhibits the required somatic symptoms, specifically fatigue, muscle tension, and sleep disturbance. The normal physical exam, normal TSH, and lack of significant substance use effectively rule out secondary causes.

Adım Adım Çözüm

1
Analyze the temporal characteristics of the patient's anxiety symptoms.
The patient has experienced constant worry for 8 months, which exceeds the 6-month threshold required for chronic anxiety conditions.
Duration of symptoms is a key differentiator between acute stress, adjustment disorders, and generalized anxiety.
2
Assess the nature and focus of the patient's worry.
The worry is excessive, uncontrollable, and spans multiple domains (work, family, finances), accompanied by somatic symptoms like muscle tension and insomnia.
This confirms the 'generalized' nature of the anxiety, ruling out specific phobias, panic attacks, or single-stressor conditions.
3
Rule out medical and substance-induced etiologies.
A normal TSH rules out hyperthyroidism; minimal caffeine intake and no illicit drug use make substance-induced anxiety highly unlikely.
Psychiatric diagnoses are diagnoses of exclusion regarding underlying physiological or substance-related causes.

Anahtar Kavram

Diagnosis of Generalized Anxiety Disorder (GAD)
Soru 68Soru →

A 27-year-old male graphic designer is brought to the emergency department by his roommate. The patient has not left his bedroom for the past 3 weeks, has been eating very little, and sleeps up to 14 hours a day. The roommate notes that for the last 5 days, the patient has been repeatedly whispering to himself and claiming that "the authorities have hidden listening devices in the ceiling." Past psychiatric history is notable for an involuntary psychiatric admission 4 years ago due to severe agitation, grandiose beliefs of having superhuman abilities, and pressured speech; that episode lasted 12 days. The patient's medical history is significant for a recent ankle sprain, for which he is currently taking tramadol. Mental status examination reveals a disheveled appearance, poor eye contact, profound psychomotor retardation, and a restricted affect. He confirms hearing a male voice calling him a "traitor." Vital signs are within normal limits. Which of the following is the most appropriate management plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Admit to the inpatient psychiatric unit and start quetiapine

Cevap

Admit to the inpatient psychiatric unit and start quetiapine
The patient's history of a prior manic episode necessitating hospitalization confirms a diagnosis of Bipolar I disorder. He is currently presenting with a severe major depressive episode complicated by mood-congruent psychotic features (delusions of surveillance and derogatory auditory hallucinations) and a dangerous decline in self-care (poor oral intake, extreme hypersomnia). Inpatient psychiatric admission is indicated for patient safety and acute stabilization. The pharmacologic treatment of choice for severe bipolar depression with psychotic features is an atypical antipsychotic that has proven efficacy in the depressive phase of bipolar disorder, such as quetiapine. Quetiapine will simultaneously target the severe depressive symptoms and the acute psychosis.

Adım Adım Çözüm

1
Analyze the past psychiatric history
The patient had a 12-day episode of severe agitation, grandiosity, and pressured speech requiring hospitalization.
This establishes a definitive history of a manic episode, confirming the diagnosis of Bipolar I disorder.
2
Evaluate the current presentation and timeline
The patient is experiencing a 3-week major depressive episode with concurrent psychotic features (delusions of persecution, auditory hallucinations) that began 5 days ago.
This determines that the current diagnosis is Bipolar I disorder, current episode depressed, severe, with mood-congruent psychotic features.
3
Determine the optimal treatment setting and pharmacotherapy
The patient requires inpatient admission due to severe functional impairment (poor oral intake, profound withdrawal), and should be started on an atypical antipsychotic like quetiapine.
Inpatient admission ensures safety. Quetiapine is a first-line monotherapy that effectively treats both bipolar depression and the concurrent psychotic symptoms without risking a manic switch.

Anahtar Kavram

Patients with Bipolar I disorder who present with a severe depressive episode and psychotic features require treatment with an atypical antipsychotic approved for bipolar depression (e.g., quetiapine, lurasidone) and often necessitate inpatient stabilization. Antidepressant monotherapy must be strictly avoided.
Tahmini Süre:1m 30s
Soru 69Soru →

A 26-year-old female dental hygienist comes to the outpatient psychiatry clinic reporting two months of profound sadness, lack of motivation, and sleeping 12 to 14 hours a day. She states she has lost interest in her usual hobbies and feels intense, inappropriate guilt regarding a recent decline in her work performance. She has gained 5 kg (11 lb) over this period. Her medical history is unremarkable, and she currently takes no medications. Vital signs and physical examination are within normal limits. When specifically asked about past mood fluctuations, the patient recalls a distinct five-day period during her sophomore year of college when she felt "supercharged." During that time, she required only 3 hours of sleep per night, started multiple complex art projects, and felt highly productive. That period did not result in hospitalization or significant functional impairment. Mental status examination today reveals a cooperative woman with a blunted affect, psychomotor retardation, and slow speech. She denies suicidal ideation, auditory hallucinations, and paranoia. Which of the following is the most appropriate next step in pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Quetiapine

Cevap

Quetiapine
The correct answer is Quetiapine. This patient's current presentation of hypersomnia, hyperphagia, and profound sadness indicates a major depressive episode. However, her history of a five-day period of elevated mood, decreased need for sleep, and increased goal-directed activity without significant functional impairment or hospitalization perfectly describes a hypomanic episode. Therefore, her diagnosis is Bipolar II disorder. The first-line pharmacological treatment for acute bipolar depression includes certain second-generation antipsychotics (such as quetiapine, lurasidone, and cariprazine) or the mood stabilizer lamotrigine. Quetiapine provides acute relief of depressive symptoms without the high risk of inducing a manic switch.

Adım Adım Çözüm

1
Analyze the patient's presenting symptoms and psychiatric history.
The patient is currently in a major depressive episode (sadness, hypersomnia, weight gain) but has a history of a distinct 5-day period of elevated mood, decreased need for sleep, and increased activity without severe impairment.
Identifying past mood episodes is necessary to differentiate unipolar major depressive disorder from bipolar spectrum disorders.
2
Establish the correct diagnosis based on DSM-5 criteria.
The diagnosis is Bipolar II disorder, characterized by at least one major depressive episode and at least one hypomanic episode (lasting ≥\geq 4 days).
Accurate diagnosis dictates the pharmacological approach and prevents harmful prescribing errors.
3
Select the appropriate pharmacotherapy for acute bipolar depression.
Quetiapine is selected. All traditional antidepressant monotherapies are contraindicated.
Antidepressant monotherapy can precipitate a manic switch. Quetiapine is an FDA-approved second-generation antipsychotic for treating acute bipolar depression.

Anahtar Kavram

Patients presenting with major depressive episodes must be screened for past manic or hypomanic episodes to rule out bipolar disorder; if bipolar disorder is diagnosed, antidepressant monotherapy is contraindicated due to the risk of a manic switch, and agents like quetiapine, lurasidone, or lamotrigine should be used.
Soru 70Soru →

A 42-year-old woman is evaluated in the psychiatric clinic and diagnosed with a moderate major depressive episode without psychotic features. Over the next 18 months, she requires multiple adjustments to her treatment plan due to inadequate symptom relief. Ultimately, her condition deteriorates, and she develops severe psychotic depression with delusions of guilt and total refusal to consume food or fluids. According to standard clinical guidelines for the stepped-care management of major depressive disorder, arrange the following therapeutic interventions in the most appropriate chronological sequence of escalation.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence of treatment escalation begins with initiating SSRI monotherapy, followed by switching to an SNRI after an initial non-response, then augmenting with an atypical antipsychotic for partial response, and finally utilizing electroconvulsive therapy (ECT) when the patient develops life-threatening psychotic features and food refusal.
The management of major depressive disorder (MDD) follows a sequential, stepped-care model based on treatment response and symptom severity. For a newly diagnosed, uncomplicated episode, first-line treatment is SSRI monotherapy. If an adequate trial (typically 4-8 weeks at a therapeutic dose) yields no significant improvement, standard guidelines recommend switching to another first-line antidepressant, such as an SNRI or a different SSRI. If a subsequent trial yields a partial response, the addition of an augmenting agent (e.g., an atypical antipsychotic, lithium, or triiodothyronine) is indicated to boost efficacy. Finally, if the patient's condition continues to worsen and they develop life-threatening symptoms—such as psychotic features (delusions/hallucinations), severe suicidality, or refusal to eat and drink—electroconvulsive therapy (ECT) becomes the most urgent and effective treatment of choice.

Adım Adım Çözüm

1
Determine the first-line pharmacotherapy for an initial diagnosis of unipolar major depressive disorder.
Initiation of SSRI monotherapy.
SSRIs have a favorable side-effect profile and are the gold standard for initiating MDD treatment.
2
Identify the standard clinical step when a patient exhibits minimal to no response after an adequate SSRI trial (4-8 weeks).
Switching to a different antidepressant (e.g., an SNRI).
Switching monotherapy is preferred over early polypharmacy when the initial agent provides virtually no benefit.
3
Determine the appropriate intervention when a patient achieves only a partial response to a subsequent antidepressant trial.
Augmentation of the current regimen with an evidence-based adjunct (e.g., an atypical antipsychotic).
Augmentation maximizes the partial benefit already achieved by the current antidepressant while minimizing the risk of losing that progress by switching again.
4
Identify the primary indication for electroconvulsive therapy (ECT) in the context of progressive clinical deterioration.
Admission and administration of ECT.
The development of psychotic features and refusal to eat or drink constitutes a psychiatric emergency requiring the rapid, definitive efficacy provided by ECT.

Anahtar Kavram

Stepped-care pharmacological escalation and indications for electroconvulsive therapy in major depressive disorder
Soru 71Soru →

A 38-year-old man with a history of schizophrenia is brought to the emergency department by police due to erratic behavior in public. In the triage area, he becomes increasingly agitated, pacing rapidly, clenching his fists, and shouting that the hospital staff are 'government spies trying to poison him.' He has not physically assaulted anyone but is blocking the exit and refusing to sit down. Arrange the following interventions for managing this patient's acute agitation in the most appropriate sequential order, applying the psychiatric principle of the least restrictive alternative.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence follows the 'least restrictive alternative' protocol: ensure safety, attempt verbal de-escalation, offer voluntary oral medications, use involuntary chemical restraints, and finally, use physical restraints only as a last resort.
The management of an acutely agitated patient must always strictly follow the principle of the least restrictive alternative. The sequence begins with ensuring environmental safety. This is followed by verbal de-escalation, which is the least coercive clinical approach. If this fails, the next step is offering voluntary oral medications. If the patient refuses and continues to escalate toward danger, chemical restraints (involuntary intramuscular medications) are utilized. Physical restraints are the absolute most restrictive measure and are reserved solely as a last resort when there is an immediate, unmanageable threat of physical violence.

Adım Adım Çözüm

1
Prioritize immediate safety.
Staff maintains distance and clears the room.
Before interacting with a potentially violent patient, ensuring the physical safety of the healthcare team and the environment is paramount.
2
Initiate verbal de-escalation.
The clinician speaks calmly and provides clear, non-threatening choices.
This is the least restrictive clinical intervention and often successfully diffuses tension without the need for medication.
3
Offer voluntary oral medication.
The patient is given the option to take a pill (e.g., a benzodiazepine or antipsychotic).
Voluntary treatment preserves patient autonomy and is far less restrictive and traumatic than forced injections.
4
Administer chemical restraint if necessary.
Intramuscular medication is given involuntarily.
If verbal methods and voluntary medication fail and the patient remains a danger, chemical restraint is safer and less restrictive than physical restraints.
5
Apply physical restraints as a final measure.
The patient is mechanically restrained to the bed.
This is the most restrictive and potentially dangerous intervention, strictly reserved for imminent physical danger when all other methods are ineffective.

Anahtar Kavram

Management of acute agitation using the least restrictive alternative
Soru 72Soru →

A 1616-year-old boy is brought to the emergency department by his parents due to progressive muscle weakness over the past 2424 hours. He is currently unable to stand without assistance. His parents note that he has been increasingly irritable and performing poorly in school for the past 44 months. Two weeks ago, his primary care provider prescribed fluoxetine for suspected depression, but his behavior has not improved. A routine thyroid panel obtained at that clinic visit showed a thyroid-stimulating hormone (TSH) level of 4.54.5 μ\mu U/mL (normal: 0.4−4.00.4-4.0 μ\mu U/mL) and a normal free T4. On physical examination, temperature is 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure is 110/70110/70 mmHg, pulse is 9292/min, and respirations are 2222/min. He appears lethargic. There is an erythematous, scaling rash localized around his mouth and nose. Neurologic examination reveals symmetrical proximal and distal muscle weakness in all extremities, with diminished deep tendon reflexes. Laboratory studies show:

Serum sodium: 140140 mEq/L
Serum potassium: 2.12.1 mEq/L
Serum chloride: 115115 mEq/L
Serum bicarbonate: 1414 mEq/L

Arterial blood gas (room air):
pH: 7.287.28
pCO 2_2: 3030 mmHg

Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Toluene inhalation

Cevap

The most likely diagnosis is toluene inhalation, which characteristically presents with a perioral rash, normal anion gap metabolic acidosis, and profound hypokalemia causing muscle weakness.
The correct diagnosis is toluene inhalation. Toluene is a volatile solvent found in paint thinners, glues, and rubber cements. Inhalant use disorder typically affects adolescents and presents with transient euphoria, lethargy, and behavioral changes. A classic physical finding is the "glue sniffer's rash," an erythematous dermatitis around the mouth and nares caused by the drying effects of the solvent. Metabolically, toluene is converted in the liver to hippuric acid. The rapid renal excretion of hippurate obligates the loss of sodium and potassium, leading to severe hypokalemia. This process also causes a distal (Type 1) renal tubular acidosis, which manifests as a normal anion gap metabolic acidosis (NAGMA). In this patient, the anion gap is 140−(115+14)=11140 - (115 + 14) = 11 mEq/L (normal: 8−128-12 mEq/L). The profound hypokalemia (2.12.1 mEq/L) is the direct cause of his acute, symmetrical muscle weakness and diminished deep tendon reflexes.

Adım Adım Çözüm

1
Analyze the acid-base status using the arterial blood gas and serum electrolytes.
The pH of 7.287.28 and HCO 3_3 of 1414 mEq/L indicate a metabolic acidosis. The anion gap is calculated as 140−(115+14)=11140 - (115 + 14) = 11 mEq/L, which is within the normal range (8−128-12 mEq/L).
Differentiating between normal and high anion gap metabolic acidosis is the critical first step in determining the etiology of the metabolic derangement.
2
Evaluate the respiratory compensation using Winter's formula.
Expected pCO 2_2 = (1.5×14)+8±2=29±2(1.5 \times 14) + 8 \pm 2 = 29 \pm 2 mmHg. The measured pCO 2_2 is 3030 mmHg, indicating appropriate respiratory compensation.
This confirms a pure normal anion gap metabolic acidosis (NAGMA) without a superimposed respiratory acid-base disorder.
3
Synthesize the metabolic findings (NAGMA, severe hypokalemia) with the clinical presentation (adolescent, behavioral changes, perioral rash, acute weakness).
The combination of NAGMA, profound hypokalemia (2.12.1 mEq/L) leading to areflexic weakness, and a "glue sniffer's rash" points directly to toluene toxicity.
Toluene is an inhalant metabolized to hippuric acid, which obligates the renal excretion of potassium, causing a Type 1 (distal) renal tubular acidosis.

Anahtar Kavram

Toluene inhalation (glue sniffing) classically presents with a perioral rash, behavioral changes, and a distal (Type 1) renal tubular acidosis, characterized by a normal anion gap metabolic acidosis and severe hypokalemia.
Tahmini Süre:2m 0s
Soru 73Soru →

A 54-year-old woman is brought to the emergency department by her daughter due to progressive confusion, unsteadiness, and shaking. The patient has a history of bipolar I disorder that has been well controlled on a stable dose of lithium for the past 8 years. Two weeks ago, she visited a primary care clinic for routine evaluation and was started on a new daily medication. Today, her temperature is 37.1°C (98.8°F), blood pressure is 128/78 mm Hg, and heart rate is 82/min. Physical examination reveals an unsteady, broad-based gait and a coarse tremor in both hands. Deep tendon reflexes are 3+ bilaterally. She also reports several days of nausea, vomiting, and diarrhea. Which of the following medications was most likely added to her regimen two weeks ago?

Cevabı ve açıklamayı göster

Cevap: Hydrochlorothiazide

Cevap

Hydrochlorothiazide
The patient's presentation of confusion, ataxia, a coarse tremor, hyperreflexia, and gastrointestinal distress (nausea, vomiting, diarrhea) in the setting of chronic lithium therapy is highly characteristic of acute-on-chronic lithium toxicity. Lithium has a very narrow therapeutic index and is eliminated almost entirely by the kidneys. Thiazide diuretics (e.g., hydrochlorothiazide) inhibit the Na+/Cl- cotransporter in the distal convoluted tubule. This leads to mild volume depletion, which stimulates the kidneys to compensatorily increase sodium reabsorption in the proximal tubule. Because lithium is handled similarly to sodium in the proximal tubule, its reabsorption is concurrently increased, severely decreasing its clearance and precipitating toxicity. Other common drugs that increase lithium levels include NSAIDs, ACE inhibitors, and tetracyclines.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and medication history.
The patient is on chronic lithium therapy and presents with acute neurologic (confusion, ataxia, coarse tremor, hyperreflexia) and gastrointestinal (nausea, vomiting, diarrhea) symptoms.
Identifying the clinical syndrome is necessary to determine the underlying pathophysiology.
2
Synthesize the findings to establish a diagnosis.
The combination of these specific neurologic and GI findings in a patient taking lithium is the classic presentation of acute-on-chronic lithium toxicity.
Lithium has a narrow therapeutic index and specific toxidrome characteristics.
3
Identify potential triggers for the toxicity based on the timeline.
A new medication was added two weeks ago. Medications that classically decrease lithium clearance include thiazide diuretics, NSAIDs, ACE inhibitors, and tetracyclines.
Lithium is almost exclusively excreted by the kidneys, and drugs affecting renal sodium handling alter its clearance.
4
Select the correct medication from the given options.
Hydrochlorothiazide is a thiazide diuretic that causes volume depletion, leading to increased proximal tubule reabsorption of both sodium and lithium, thereby precipitating toxicity.
This directly explains the patient's presentation following the addition of the new drug.

Anahtar Kavram

Lithium Toxicity and Drug Interactions
Soru 74Soru →

A 24-year-old man is recently diagnosed with schizophrenia and is currently treatment-naive. Assuming he experiences sequential medication failures due to lack of efficacy at each stage of his treatment, arrange the following management steps in the correct sequential order according to standard pharmacotherapy algorithms.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Initiate a first-line antipsychotic, 2) Switch to a different first-line antipsychotic, 3) Initiate clozapine, and 4) Augment clozapine with ECT or another agent.
The standard algorithm for treating schizophrenia begins with a trial of a first-line antipsychotic. If this is unsuccessful, the patient is switched to a different standard antipsychotic. Failing two adequate trials defines treatment-resistant schizophrenia, for which clozapine is the drug of choice. If clozapine fails, augmentation strategies (like ECT) are indicated.

Adım Adım Çözüm

1
Identify the initial treatment for a treatment-naive patient with schizophrenia.
Initiate a first-line antipsychotic (e.g., risperidone).
Standard first- and second-generation antipsychotics are the appropriate initial choice.
2
Determine the next step after a single antipsychotic trial fails.
Switch to a different first-line antipsychotic.
A single failure does not define treatment resistance; a second trial of a different standard agent is required.
3
Determine the management after two adequate trials of different antipsychotics have failed.
Initiate treatment with clozapine.
Failure of two trials defines treatment-resistant schizophrenia, which is the primary indication for clozapine.
4
Determine the next step if clozapine monotherapy is inadequate.
Augment clozapine with ECT or a second antipsychotic.
Clozapine-resistant schizophrenia requires augmentation strategies.

Anahtar Kavram

Pharmacotherapy sequencing algorithm for schizophrenia and treatment resistance
Soru 75Soru →

A 16-year-old boy is brought to the physician by his parents due to behavioral changes and declining school performance over the past three months. The parents report that he has been isolating himself in his bedroom, and they recently discovered a stash of empty computer duster aerosol cans under his bed. When questioned, the patient is evasive, irritable, and refuses to make eye contact. Vital signs are within normal limits. On physical examination, the patient has a mildly broad-based gait and slight dysarthria. An erythematous, eczematous rash is observed surrounding his mouth and nostrils. This patient's current substance use places him at greatest risk for which of the following life-threatening complications?

Cevabı ve açıklamayı göster

Cevap: Fatal ventricular arrhythmia

Cevap

Fatal ventricular arrhythmia
The patient's presentation of behavioral changes, cerebellar symptoms (ataxia, dysarthria), a perioral/perinasal rash ('glue sniffer's rash'), and a history of hoarding aerosol cans is highly characteristic of inhalant abuse. Aerosol dusters contain volatile fluorocarbons. A major, acute, life-threatening complication of volatile solvent and aerosol abuse is 'sudden sniffing death syndrome.' This occurs because the highly lipophilic inhaled chemicals rapidly cross the blood-brain barrier and strongly sensitize the myocardium to endogenous catecholamines. A sudden surge in catecholamines (e.g., if the user is startled, physically active, or running from parents) can trigger a fatal ventricular arrhythmia, such as ventricular fibrillation, even in previously healthy adolescents.

Adım Adım Çözüm

1
Identify the primary substance of abuse from the clinical clues.
The patient uses computer duster aerosols and presents with a perioral rash ('glue sniffer's rash') alongside cerebellar signs (ataxia, dysarthria), confirming volatile inhalant abuse.
Recognizing the specific substance toxidrome is essential for anticipating related physiological complications.
2
Determine the pathophysiological effects of volatile inhalants on the body.
Inhalants act as rapid CNS depressants but crucially sensitize the myocardium to endogenous catecholamines.
Understanding the systemic effects beyond the central nervous system explains the mechanism of acute mortality.
3
Identify the most lethal acute complication associated with this mechanism.
Sensitized myocardium in the presence of a sudden catecholamine surge (e.g., being startled or exercising) leads to fatal ventricular arrhythmias, commonly known as 'sudden sniffing death syndrome'.
This directly answers the question regarding the greatest life-threatening risk for this patient.

Anahtar Kavram

Inhalant abuse (e.g., volatile solvents, aerosols) classically presents with perioral dermatitis and CNS depression, and uniquely predisposes patients to 'sudden sniffing death syndrome' via myocardial sensitization to catecholamines, resulting in fatal ventricular arrhythmias.
Soru 76Soru →

A 20-year-old female college student is brought to the student health clinic by her roommate due to severe generalized weakness, muscle cramps, and dizziness upon standing. The patient admits to having an intense fear of gaining weight and reveals that she has been using over-the-counter pills to "stay thin", though she refuses to specify the exact medication. Her body mass index is 22 kg/m222 \text{ kg/m}^2. Vital signs show a blood pressure of 105/65 mm Hg supine and 85/50 mm Hg standing. Pulse is 92/min supine and 118/min standing. Physical examination is unremarkable, with no dental erosions or calluses on her hands. Laboratory studies show:

Sodium: 139 mEq/L139 \text{ mEq/L}
Potassium: 2.6 mEq/L2.6 \text{ mEq/L}
Chloride: 115 mEq/L115 \text{ mEq/L}
Bicarbonate: 14 mEq/L14 \text{ mEq/L}

Arterial blood gas on room air:
pH: 7.287.28
pCO2pCO_2: 30 mm Hg30 \text{ mm Hg}

Which of the following inappropriate compensatory behaviors is most likely responsible for this patient's laboratory findings?

Cevabı ve açıklamayı göster

Cevap: Frequent use of bisacodyl

Cevap

Frequent use of bisacodyl
The correct answer is the frequent use of bisacodyl. This patient presents with orthostatic hypotension, severe hypokalemia, and a normal anion gap metabolic acidosis. In the context of a patient with an eating disorder, these findings are highly specific for laxative abuse (such as bisacodyl or senna). Laxatives cause rapid gastrointestinal transit and profound loss of potassium-rich and bicarbonate-rich fluids in the stool. The loss of bicarbonate directly causes a non-anion gap metabolic acidosis, and the loss of potassium leads to severe hypokalemia.

Adım Adım Çözüm

1
Identify the primary acid-base disturbance.
The pH is 7.287.28 (acidemia) and bicarbonate is 14 mEq/L14 \text{ mEq/L} (low), indicating a primary metabolic acidosis.
To determine the primary etiology of the electrolyte derangement.
2
Calculate the anion gap and expected respiratory compensation.
The anion gap is 139−(115+14)=10 mEq/L139 - (115 + 14) = 10 \text{ mEq/L}, which is normal. Expected pCO2pCO_2 by Winter's formula is 1.5(14)+8±2=29±2 mm Hg1.5(14) + 8 \pm 2 = 29 \pm 2 \text{ mm Hg}, matching the measured 30 mm Hg30 \text{ mm Hg}.
To differentiate between normal anion gap and high anion gap metabolic acidosis, and to confirm there is no mixed disorder.
3
Correlate the laboratory findings with eating disorder behaviors.
The combination of severe hypokalemia, volume depletion, and a normal anion gap metabolic acidosis points to lower gastrointestinal loss of bicarbonate and potassium.
To identify the specific mechanism (laxative abuse) among the differential diagnoses for inappropriate compensatory weight-loss behaviors.

Anahtar Kavram

Patients with eating disorders who abuse laxatives typically present with volume depletion, severe hypokalemia, and a normal anion gap metabolic acidosis due to gastrointestinal loss of bicarbonate and potassium.
Soru 77Soru →

A 28-year-old male fitness coach presents to the psychiatry clinic with a 5-week history of profound sadness, anhedonia, and sleeping up to 14 hours a day. He reports significant fatigue and difficulty concentrating on his clients' workout plans. Past psychiatric history reveals an episode 3 years ago characterized by 10 days of feeling "invincible," sleeping only 2 hours nightly, and maxing out several credit cards to start an ill-advised supplement company. His medical history is unremarkable. Vital signs are within normal limits. Mental status examination reveals psychomotor retardation, poor eye contact, and a constricted affect. Which of the following pharmacological interventions are appropriate for the acute management of this patient's current episode? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Prescribe lurasidone; Prescribe olanzapine combined with fluoxetine

Cevap

The appropriate interventions are prescribing lurasidone and prescribing olanzapine combined with fluoxetine.
The patient's presentation of a major depressive episode accompanied by a clear history of a manic episode (decreased need for sleep, grandiosity, and severe impulsivity lasting at least 7 days) confirms the diagnosis of Bipolar I Disorder, currently in a depressed episode. The pharmacological treatment of acute bipolar depression differs significantly from unipolar depression. First-line treatments with demonstrated efficacy and safety include lurasidone, quetiapine, cariprazine, and the olanzapine-fluoxetine combination. These agents target depressive symptoms without excessively risking mood destabilization.

Adım Adım Çözüm

1
Evaluate the current presenting symptoms.
The patient has a 5-week history of profound sadness, anhedonia, hypersomnia, and fatigue.
These symptoms fulfill the DSM-5 criteria for a major depressive episode.
2
Analyze the patient's past psychiatric history.
The patient experienced a 10-day episode of grandiosity, decreased need for sleep, and severe impulsivity (financial irresponsibility).
This distinct period of elevated mood and increased energy lasting over 7 days confirms a past manic episode.
3
Formulate the correct overarching diagnosis.
The combination of a lifetime manic episode and a current depressive episode yields a diagnosis of Bipolar I Disorder, current episode depressed.
A single manic episode is sufficient to diagnose Bipolar I Disorder, distinguishing it from Major Depressive Disorder.
4
Determine the appropriate evidence-based pharmacological treatments.
Lurasidone and the olanzapine-fluoxetine combination are selected.
These medications are first-line treatments with established efficacy for acute bipolar depression that do not carry the high risk of mood destabilization seen with antidepressant monotherapy.

Anahtar Kavram

The first-line pharmacological management of acute bipolar depression includes agents such as lurasidone, quetiapine, cariprazine, or the olanzapine-fluoxetine combination, while strictly avoiding antidepressant monotherapy.
Soru 78Soru →

A 29-year-old man comes to the primary care clinic for a routine physical examination required by his employer. He works as a night-shift security guard, a job he specifically chose to minimize interaction with others. He is wearing a heavy winter coat despite the hot summer weather, and he has multiple protective amulets around his neck. He speaks in a vague, metaphorical manner, explaining that he can 'feel the auras' of people around him and often senses an invisible 'presence' when alone. However, he denies hearing voices and does not hold any fixed, false beliefs when his thoughts are gently challenged by the physician. He reports having no friends other than his parents. He experiences severe anxiety in social situations, which he attributes to others harboring 'dark energy,' and notes this anxiety does not improve even when he spends more time with people. He states he has been this way since adolescence. Which of the following statements regarding this patient's clinical presentation are correct? (Select 2)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: The patient's presentation is characteristic of a Cluster A personality disorder.; The social anxiety experienced by this patient typically does not diminish with familiarity.

Cevap

The correct statements identify the condition as a Cluster A personality disorder and note that the associated social anxiety does not diminish with familiarity.
The patient exhibits classic features of schizotypal personality disorder, which belongs to the Cluster A (odd/eccentric) group. Key features include magical thinking, ideas of reference, unusual perceptual experiences, and odd speech. Furthermore, a distinguishing feature of schizotypal personality disorder is that social anxiety tends to remain high even with familiar people, as it is driven by paranoid fears rather than concerns about being judged negatively.

Adım Adım Çözüm

1
Analyze the patient's symptoms and timeline.
The patient exhibits eccentric behavior, magical thinking, odd speech, and social anxiety based on paranoid fears, present since adolescence.
To identify the core psychiatric syndrome and chronicity.
2
Evaluate for the presence of frank psychosis.
The patient lacks true hallucinations and fixed delusions.
To rule out primary psychotic disorders like schizophrenia or schizophreniform disorder.
3
Differentiate from other personality disorders.
The anxiety stems from paranoia rather than fear of negative evaluation.
To confirm schizotypal personality disorder and rule out avoidant personality disorder.

Anahtar Kavram

Diagnosis and clinical features of Schizotypal Personality Disorder
Soru 79Soru →

A 58-year-old man is brought to the clinic by his husband due to a 14-month history of progressive behavioral changes. Previously known as a meticulous and empathetic high school teacher, the patient has become increasingly apathetic and frequently makes sexually explicit remarks to neighbors. He recently ate a stranger's sandwich off their plate at a local restaurant and showed no remorse when confronted by the staff. He denies feeling sad or anxious, stating, "Everything is perfectly fine." The patient has a remote history of a single depressive episode in his 20s. He takes over-the-counter diphenhydramine occasionally for sleep but takes no prescription medications. Vital signs are within normal limits. Laboratory studies, including a thyroid-stimulating hormone (TSH) level of 1.2 mU/L and a free T4 of 1.2 ng/dL (normal: 0.8-1.8 ng/dL), are normal. On mental status examination, he has a blunted affect and poor insight, but no delusions or hallucinations are elicited. Montreal Cognitive Assessment (MoCA) score is 23/30; he loses points primarily on clock drawing and verbal fluency tasks, but successfully recalls 3 out of 3 objects after a 5-minute delay. Neurological examination reveals no focal weakness, rigidity, or resting tremor. Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Frontotemporal neurocognitive disorder

Cevap

Frontotemporal neurocognitive disorder
The correct answer is frontotemporal neurocognitive disorder. The behavioral variant of frontotemporal dementia (bvFTD) typically presents between the ages of 50 and 60. It is characterized by an insidious onset and gradual progression of profound personality changes, social disinhibition (e.g., making sexually explicit remarks to neighbors, stealing food), apathy, and hyperorality (changes in eating behaviors, such as eating off a stranger's plate). On formal cognitive testing, patients demonstrate marked executive dysfunction, often struggling with verbal fluency and clock drawing. Notably, visuospatial skills and memory are relatively preserved in the early stages, distinguishing it from Alzheimer disease. This patient's clinical picture perfectly aligns with bvFTD.

Adım Adım Çözüm

1
Analyze the patient's demographic profile and the timeline of the symptoms.
The patient is a 58-year-old man with a 14-month insidious, progressive history of symptoms, which strongly suggests an early-onset primary neurocognitive disorder rather than an acute process like delirium or a typical psychiatric onset.
Establishing the tempo and age of onset narrows the differential diagnosis between acute, psychiatric, and neurodegenerative etiologies.
2
Evaluate the specific clinical features and mental status examination findings.
The patient exhibits prominent personality changes, disinhibition (inappropriate sexual remarks, stealing food), hyperorality (eating off others' plates), and executive dysfunction (poor clock drawing and verbal fluency), with relatively preserved memory (3/3 recall).
Different neurocognitive disorders have distinct early clinical hallmarks; characterizing the prominent deficits leads to the specific subtype.
3
Synthesize findings to identify the most likely diagnosis.
The combination of early personality changes, disinhibition, hyperorality, and prominent executive dysfunction with spared memory in a patient under 60 is the classic presentation of behavioral variant frontotemporal neurocognitive disorder.
Matching the symptom cluster to diagnostic criteria confirms the underlying etiology.

Anahtar Kavram

Recognizing the clinical presentation of behavioral variant frontotemporal dementia (bvFTD), which is characterized by early personality changes, disinhibition, apathy, and executive dysfunction with relatively preserved memory.
Tahmini Süre:1m 15s
Soru 80Soru →

A 72-year-old woman is evaluated in the outpatient geriatric clinic due to progressive memory impairment and behavioral changes. According to her son, who accompanies her, she has experienced significant day-to-day fluctuations in her alertness and attention over the last 10 months. Furthermore, she frequently describes seeing detailed, silent figures of people standing in her bedroom. Her sleep is often restless, and she frequently shouts and thrashes her arms as if she is acting out her dreams. On physical examination, the patient has a mask-like facial expression, a resting tremor in her left hand, and cogwheel rigidity in both upper extremities. The physician explains the likely diagnosis to the son and discusses management options. The physician strongly cautions against the use of a specific class of medications to treat her perceptual disturbances, noting that it could trigger a severe, potentially fatal reaction characterized by irreversible parkinsonism and autonomic dysfunction. Which of the following medications is most likely to cause the severe reaction described by the physician?

Cevabı ve açıklamayı göster

Cevap: Haloperidol

Cevap

Haloperidol
This patient's clinical presentation is classic for Dementia with Lewy bodies (DLB), which is characterized by fluctuating cognition, recurrent well-formed visual hallucinations, REM sleep behavior disorder (acting out dreams), and spontaneous parkinsonism. A hallmark feature of DLB is severe neuroleptic sensitivity. Administration of first-generation (typical) antipsychotics, such as haloperidol, or some second-generation antipsychotics with strong dopamine D2 antagonism (e.g., risperidone), can precipitate a life-threatening reaction. This reaction is characterized by a dramatic worsening of parkinsonism, severe muscle rigidity, autonomic instability, and impaired consciousness. Because of this high risk, typical antipsychotics like haloperidol are strictly contraindicated in patients with DLB.

Adım Adım Çözüm

1
Identify the underlying diagnosis based on the clinical presentation.
The patient has fluctuating cognition, well-formed visual hallucinations, REM sleep behavior disorder, and spontaneous parkinsonism, which are core clinical features of Dementia with Lewy bodies (DLB).
Accurate diagnosis is required to understand disease-specific pharmacological contraindications.
2
Recognize the specific pharmacological vulnerability associated with this condition.
Patients with DLB have extreme sensitivity to dopamine D2 receptor antagonists, particularly first-generation (typical) antipsychotics.
Administration of these agents can precipitate a life-threatening reaction known as severe neuroleptic sensitivity.
3
Select the medication from the options that represents this contraindicated class.
Haloperidol is a high-potency typical antipsychotic, making it highly likely to cause severe neuroleptic sensitivity in a patient with DLB.
The other medications listed are either indicated for DLB symptoms or do not cause this specific life-threatening reaction.

Anahtar Kavram

Severe neuroleptic sensitivity in Dementia with Lewy bodies (DLB)
Tahmini Süre:1m 0s
ÖncekiSayfa 4 / 41Sonraki
Psychiatry Alıştırma Soruları — USMLE Step 2 CK — Sayfa 4 | Examkin